313 related articles for article (PubMed ID: 25430073)
1. Correlation between experimental human and murine skin sensitization induction thresholds.
Api AM; Basketter D; Lalko J
Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
[TBL] [Abstract][Full Text] [Related]
2. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
3. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
4. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
5. Skin sensitization testing in potency and risk assessment.
Kimber I; Basketter DA; Berthold K; Butler M; Garrigue JL; Lea L; Newsome C; Roggeband R; Steiling W; Stropp G; Waterman S; Wiemann C
Toxicol Sci; 2001 Feb; 59(2):198-208. PubMed ID: 11158712
[TBL] [Abstract][Full Text] [Related]
6. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
7. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
8. Risk Assessment of residual monomer migrating from acrylic polymers and causing Allergic Contact Dermatitis during normal handling and use.
Pemberton MA; Lohmann BS
Regul Toxicol Pharmacol; 2014 Aug; 69(3):467-75. PubMed ID: 24859074
[TBL] [Abstract][Full Text] [Related]
9. Reproducible prediction of contact allergenic potency using the local lymph node assay.
Basketter DA; Cadby P
Contact Dermatitis; 2004 Jan; 50(1):15-7. PubMed ID: 15059097
[TBL] [Abstract][Full Text] [Related]
10. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
Durand G; de Burlet G; Virat M; Nauman BD
Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
[TBL] [Abstract][Full Text] [Related]
11. Comparative sensitizing potencies of fragrances, preservatives, and hair dyes.
Lidén C; Yazar K; Johansen JD; Karlberg AT; Uter W; White IR
Contact Dermatitis; 2016 Nov; 75(5):265-275. PubMed ID: 27633650
[TBL] [Abstract][Full Text] [Related]
12. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
13. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
[TBL] [Abstract][Full Text] [Related]
14. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
[TBL] [Abstract][Full Text] [Related]
15. Investigation of allergenicity of some cosmetic mixtures by using ex vivo local lymph node assay-BrdU endpoints.
Ulker OC; Kaymak Y; Karakaya A
Int Arch Allergy Immunol; 2014; 164(4):301-7. PubMed ID: 25247696
[TBL] [Abstract][Full Text] [Related]
16. Human potency predictions for aldehydes using the local lymph node assay.
Basketter DA; Wright ZM; Warbrick EV; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; White IR
Contact Dermatitis; 2001 Aug; 45(2):89-94. PubMed ID: 11553118
[TBL] [Abstract][Full Text] [Related]
17. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
Takeyoshi M; Iida K; Suzuki K; Yamazaki S
J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
[TBL] [Abstract][Full Text] [Related]
18. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
19. Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.
Warbrick EV; Dearman RJ; Basketter DA; Kimber I
Contact Dermatitis; 1999 Dec; 41(6):325-9. PubMed ID: 10617213
[TBL] [Abstract][Full Text] [Related]
20. Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data.
Griem P; Goebel C; Scheffler H
Regul Toxicol Pharmacol; 2003 Dec; 38(3):269-90. PubMed ID: 14623479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]